Skip to main content
logo
PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.5000
0.00 (0.00%)
At close: Jul 31, 2026

PharmaCorp Rx Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
24.0820.895.79-
Revenue Growth
145.63%260.57%--
Gross Profit
9.478.32.18-
Operating Income
-1.14-1.29-1.6-0.58
Net Income
-1.62-1.48-1.01-0.47
Earnings Per Share
-0.01-0.01-0.01-0.01
EPS Growth
----

Revenue by Segment
Chart
Fiscal YearTTMFY 2025
Period EndingMar '26 Dec '25
Non-wholly Owned Pharmacies
7.746.24
Wholly Owned Pharmacies
16.3414.66
Total
24.0820.89

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
23.3825.8912.892.242.73
Total Debt
4.484.550.9500
Net Cash (Debt)
18.921.3411.932.242.73
Net Cash Growth
57.24%78.82%432.33%-17.99%-
Net Cash Per Share
0.130.170.150.060.08

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-0.792.010.12-0.52-0.12
Capital Expenditures
-0.15-0.09-0.01--
Free Cash Flow
-0.941.920.12-0.52-0.12
Free Cash Flow Growth
-1525.00%---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
39.32%39.72%37.69%-
Operating Margin
-4.75%-6.20%-27.66%-
Pretax Margin
-4.48%-4.00%-19.97%-
Profit Margin
-6.96%-6.81%-18.14%-
FCF Margin
-3.90%9.18%2.04%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
33.3344.00----
P/FCF Ratio
-41.28536.42---
PS Ratio
3.623.7910.93---